One thing patients must understand when taking medicine: What disease does Aceminib treat?

Asciminib (Asciminib) is a cancer drug. It is used to treat chronic myelogenous leukemia (CML), a cancer of the white blood cells that is in the "chronic" stage (this means the disease develops slowly and patients have few or no symptoms). This drug is available to adults whose cancer is Philadelphia chromosome positive (Ph+). Ph+ means that the patient's two chromosomes have rearranged and formed a special chromosome called the Philadelphia chromosome. This chromosome produces an enzyme, BCR::ABL1 kinase, that leads to the development of leukemia.

Aximinib is used in patients who have been treated with two or more cancer drugs called tyrosine kinase inhibitors. Chronic myelogenous leukemia is rare, and aceminib was designated as an "orphan drug" (a drug for rare diseases) in March 2020. Aceminid is only available by prescription, and treatment must be started by a doctor experienced in diagnosing and treating leukemia. Aceminib is available in tablet form and is recommended for patients to take orally twice a day.

The original drug of Asiminib has not yet been launched in China, so it cannot be included in medical insurance. The original drug of Asiminil sold overseas is very expensive, and the price of 20mg*60 oral tablets is about more than 20,000 US dollars (the price may fluctuate due to the exchange rate). There are also Assimini generic drugs produced and marketed overseas, and their drug ingredients are basically the same as those of the original drug. For example, the price of 40mg*60 tablets produced by a Laos pharmaceutical factory may be more than 4,000 yuan per box (the price may fluctuate due to exchange rates). The price is relatively cheap. For more information about overseas drugs and specific prices, please consult Yaode Medical Consultant.